Chapter 19 Cryopreservation Effect on Genetic Function: Neonatal Outcomes.

Methods Mol Biol

Department of Molecular Biology, Cell Biology Area, University of León, Campus de Vegazana s/n, León, 24071, León, Spain.

Published: May 2017


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Cryopreservation is a well-established technique commonly used in clinical practice. It is used widely for the conservation of gametes and embryos that will be used later for insemination or in vitro fertilization. However, several studies have shown that this technique can produce changes in messenger RNA levels, in the epigenome and induce DNA damage. Although the embryo has potent mechanisms for DNA repair, and molecular changes in spermatozoa are not necessarily reflected in the embryo, it is important to explore new molecular tests and diagnostic tools to design optimal cryopreservation protocols and avoid undesirable molecular alterations. This chapter describes a protocol to quantify the lesions produced by cryopreservation using a protocol previously published by Rothfuss.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6828-2_19DOI Listing

Publication Analysis

Top Keywords

chapter cryopreservation
4
cryopreservation genetic
4
genetic function
4
function neonatal
4
neonatal outcomes
4
outcomes cryopreservation
4
cryopreservation well-established
4
well-established technique
4
technique commonly
4
commonly clinical
4

Similar Publications

Engineering strategies and challenges in building the follicular microenvironment for a bioprosthetic ovary.

Best Pract Res Clin Obstet Gynaecol

September 2025

Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA; Department of Pediatrics, Division of Endocrinology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Department of Obstetrics and Gynecology, Feinberg School o

Many individuals with ovaries that utilize fertility preservation because of their progressive disease or gonadotoxic treatment must use ovarian tissue cryopreservation (OTC). Currently, the only option for fertility and hormone restoration after OTC is ovarian tissue transplantation (OTT), or autologous grafting of ovarian tissue. Individuals with disease in their ovaries do not have options to produce a biological child or restore their full ovarian hormone milieu.

View Article and Find Full Text PDF

Making fertility preservation happen for the transgender community.

Best Pract Res Clin Obstet Gynaecol

September 2025

University of Miami Miller School of Medicine, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Miami, FL, USA.

Transgender individuals, whose gender identity differs from their assigned sex at birth, may undergo gender-affirming hormone therapy (GAHT) and gender-affirming surgery (GAS) to alleviate gender dysphoria. These treatments often impact future reproductive potential, necessitating fertility preservation (FP) discussions. Healthcare guidelines from the American Society of Reproductive Medicine (ASRM), World Professional Association for Transgender Health (WPATH), and the Endocrine Society recommend counseling on FP options, which include oocyte, sperm, and embryo cryopreservation.

View Article and Find Full Text PDF

Recent advancements in agricultural biotechnology have opened new avenues for improving genetic gain and reproductive efficiency in livestock. In this context, in vitro embryo production (IVP) and cryopreservation technologies have emerged as strategic tools in modern cattle breeding programs. The ability to produce high-quality bovine blastocysts under laboratory conditions offers considerable advantages, including the preservation of elite genetics, increased fertility outcomes, and enhanced sustainability in animal production systems.

View Article and Find Full Text PDF

Analysis of Motion Characteristics and Plasma Membrane Intactness (Viability) in Sperm from Domestic Animals.

Methods Mol Biol

July 2025

Equine Fertility Laboratory, Department of Large Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA.

Sperm quality analysis using computer-assisted sperm analysis (CASA) systems and fluorescence-based techniques has become common in the animal reproduction industry, particularly for large animals (i.e., bovine, porcine, equine).

View Article and Find Full Text PDF

The Biology and Regulation of Spermatogonial Stem Cells in the Niche.

Adv Exp Med Biol

April 2025

School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, China.

Spermatogenesis, the process responsible for the daily production of millions of sperm, originates from spermatogonial stem cells (SSCs). Dysregulation of spermatogenesis is a major contributing factor to male infertility. Additionally, cryopreservation of SSCs followed by transplantation is a viable approach to restore spermatogenesis after sterilizing treatments such as chemotherapy and radiotherapy for cancer treatment.

View Article and Find Full Text PDF